FDA
approval
· 2015-05-16
FDA Approved: ALYACEN 7/7/7 — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved Glenmark's supplemental application for ALYACEN 7/7/7, a generic norethindrone/ethinyl estradiol oral contraceptive.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ALYACEN 7/7/7 (NORETHINDRONE AND ETHINYL ESTRADIOL)